Introduction
============

Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) has been a powerful and approved tool for routine diagnostics in various fields such as the food industry and clinical microbiology. In conventional routine diagnostic methods, sample bacteria are analyzed by mass spectral fingerprinting, in which the sample bacterium is identified based on the similarity of mass spectra. It has already been evaluated for identification at the genus and species levels for a wide variety of clinically important bacteria and with reliable results.^[@r01],[@r02])^ In contrast, bioinformatics-based approaches have been proposed for the rapid identification of bacteria.^[@r03],[@r04])^ In this approach, detected peaks corresponding to bacterial proteins are assigned using calculated masses from amino acid sequences that are registered in public protein databases such as UniProt Knowledgebase (UniProtKB) and NCBI protein database. In addition, ribosomal subunit proteins (RSPs) have been proposed as ideal biomarker proteins because RSPs are one of the most abundant and typical housekeeping proteins that are practical and easily detected by MALDI-MS.^[@r05],[@r06])^ However, intraspecies discrimination of bacteria is important for understanding the variety of bacterial-specific characteristics, such as virulence and drug resistance. Therefore, we developed a bacterial analysis method that discriminates bacteria at the subspecies and strain levels by MALDI-MS using RSPs as biomarkers.^[@r05],[@r07]--[@r11])^ In our previous study, the expressed RSPs from genome sequenced lactic acid bacteria strains of *Lactobacillus plantarum*,^[@r07])^ *Lactobacillus delbrueckii* subsp. *bulgaricus*, and *Streptococcus thermophilus*^[@r08])^ were examined using a bioinformatics-based approach. Although the amino acid sequences of RSPs are highly conserved, differences among same species can be detected using peak shifts, which reflect mutations in the amino acid sequences. These peak shifts are considered to be used as biomarkers for the classification of intraspecies bacterial strains. Furthermore, sixteen strains of *Pseudomonas putida* including different biovars and 21 strains of *Rhodococcus erythropolis* were classified based on profiling using RSPs detected by MALDI-MS. These obtained classification results for *P. putida* and *R. erythropolis* strains were highly similar to those based on the DNA gyrase subunit B gene sequencing.^[@r09],[@r10])^ In addition, we looked at seventeen strains of *Bifidobacterium longum*, including three subspecies, which were successfully classified at the subspecies level.^[@r11])^ In our previous studies, we have not established a name for our bacterial classification method. In this study, our proposed bacterial classification method, which uses profiling of identified biomarker peaks is designated "MALDI-MS proteotyping". This MALDI-MS proteotyping is similar to molecular typing method, multilocus sequence typing (MLST), and is based on a bioinformatics approach. Detected peaks in the MALDI mass spectra were then assigned using theoretical masses that enabled precise annotation of RSPs mutants and, therefore, can discriminate closely related bacterial strains. MALDI-MS proteotyping in which bacteria are discriminated based on sequence mutations is different from conventional mass spectral fingerprinting techniques, which are basically optimized for the identification of bacterial genera and species. MALDI-MS proteotyping is an attractive method that allows the analysis of multiple proteins independently from DNA-based techniques. However, it is necessary to compare the results of MALDI-MS proteotyping with those of genetic approaches to verify the discrimination resolution of MALDI-MS proteotyping of bacterial strains.

*C. acnes* is a Gram-positive anaerobic bacterium that is a major member of human skin commensal bacteria.^[@r12],[@r13])^ The members of *C. acnes* are classified into three types, I, II, and III, based on traditional phenotypic characteristics such as serotypes, cell-wall sugar contents, fatty acid profiles, and morphology.^[@r14]--[@r17])^ Recently, these were assigned to novel subspecies as follows: type I as *C. acnes* subsp. *acnes*,^[@r18])^ type II as *C. acnes* subsp. *defendens*,^[@r19])^ and type III as *C. acnes* subsp. *elongatum*.^[@r20])^ *C. acnes* plays an important role in maintaining skin health as a producer of propionic acid, which maintains acidic skin pH to prevent the growth of pathogens.^[@r21])^ *C. acnes* is also known as an opportunistic pathogen associated with acne vulgaris,^[@r22])^ sarcoidosis,^[@r23])^ prostate cancer,^[@r24])^ and device-related infections such as prosthetic joint infection.^[@r25],[@r26])^ Because specific *C. acnes* strains display differences in interacting with microbe-related human diseases, it seems to be important to understand the diversity of *C. acnes* at the subtype/ribotype (RT) level.^[@r27])^ *C. acnes* strains are classified into six main phylotypes, designated IA~1~, IA~2~, IB, IC, II, and III by MLST.^[@r16],[@r28]--[@r31])^ Furthermore, *C. acnes* strains were classified at the RT level based on their unique 16S rRNA sequences.^[@r27])^ MALDI-MS fingerprinting has been applied to identify *C. acnes* phylotypes using two to five unidentified peaks.^[@r17],[@r20],[@r32])^ Even though the MALDI-MS fingerprinting technique is a powerful approach for rapid phylotype identification, the phylotypes were identified based on incomplete evidence due to using unidentified two to five peaks that were detected in the range *m*/*z* 6900--7500 and their doubly charged ions (\[M + 2H\]^2+^), which were detected in the range of *m*/*z* 3450--3750. In addition, IA~2~ and IB have not been discriminated yet.^[@r17],[@r20],[@r32])^ In the present study, MALDI-MS proteotyping was applied for 24 culture collection strains of *C. acnes* including five phylotypes, IA~1~, IA~2~, IB, II, and III (IA~1~: n = 5, IA~2~: n = 4, IB: n = 4, II: n = 8, and III: n = 3). We developed a practical and reliable classification method for *C. acnes* strains at the phylotype level based on MALDI-MS proteotyping. In addition, classification of IC based on theoretical masses calculated from amino acid sequences on a protein database was also discussed.

Materials and methods
=====================

Bacterial strains.
------------------

The bacterial strains used in this study were provided by the RIKEN BRC (Tsukuba, Ibaraki, Japan) through the National BioResource Project of the MEXT/AMED, Japan. Table [1](#tbl01){ref-type="table"} summarizes the 24 sample strains of *C. acnes* with their phylotypes and MLST sequence types (STs).^[@r33])^ The sample strains were cultured in Gifu anaerobic medium (GAM) broth (Nissui Pharmaceutical Co., Tokyo, Japan) in anaerobic conditions at 37 ℃ for 48 to 72 hours.

Bacterial sample preparation.
-----------------------------

Bacterial samples were prepared at three different protein purification levels to optimize sample preparation for detecting RSPs: whole cell for the direct smear method, cell lysate for the premixed method, and protein fraction for the premixed method. Each of the 24 *C. acnes* strains were harvested by centrifugation and washed in Milli-Q water (Millipore Co., Bedford, MA, USA). The whole cell sample were bacterial cells suspended in Milli-Q water (OD600 = 1). Preparation of cell lysates was carried out based on the methods reported previously.^[@r08]--[@r10])^ Briefly, bacterial cells were ground with zirconia beads using a Micro Smash™ MS-100 (Tomy Seiko Co. Ltd., Tokyo, Japan) at 5000 rpm three times of 60 s each, and beads and cell debris were removed by centrifugation (15000 *g*, 5 min). Protein fractions were obtained by ultra-filtration of the cell lysates (14000 *g*, 10 min). Centrifugal filter devices (Amicon Ultra™, NMWL 10 kDa, Millipore Co.) were used to capture ribosome particles. The scheme is illustrated in Fig. [1](#fig01){ref-type="fig"}.

Calculation of the theoretical mass of RSPs.
--------------------------------------------

The theoretical masses of RSPs were calculated for the following genome sequenced strains used in this study, *C. acnes* subsp. *acnes* JCM 6425^T^, JCM 18916, and JCM 18918, *C. acnes* subsp. *defendens* JCM 6473^T^ and JCM 18920, *C. acnes* subsp. *elongatum* JCM18909. Amino acid sequences of each RSP were obtained from the NCBI protein database (<https://www.ncbi.nlm.nih.gov/protein/>). The calculated mass of each RSP was predicted using the Compute pI/Mw tool on the ExPASy proteomics server (<https://web.expasy.org/compute_pi_tool.html>), with N-terminal methionine loss considered first as a possible post-translational modification. The possibilities of other modifications will be discussed below in the Results and Discussion sections. The theoretical mass of each ribosomal protein was calculated as \[M + H\]^+^.

MALDI-MS.
---------

Sinapinic acid (SA) matrix solution at a concentration of 10 mg/mL in 50% acetonitrile (ACN) with 1% trifluoroacetic acid (TFA) was used for MALDI-MS sample preparation. Optimization of sample preparation was carried out using a cell suspension of *C. acnes* JCM 6425^T^ (OD600 = 1).

For the direct smear method, 1 µL of each cell suspension was spotted onto the MALDI target and dried in air. To extract RSPs from *C. acnes* strains, formic acid (FA) extraction, which was used for microorganisms such as yeasts and *Corynebacterium*, was performed.^[@r34],[@r35])^ On-plate extraction using 0.5 µL of 30% FA was carried out before dropping of 1 µL of SA solution onto the sample. For preparation of the premixed method, 1 µL of each of cell lysate or protein fraction was mixed with 10 µL of SA matrix solution. One µL of sample/matrix mixture was spotted onto the MALDI target and dried in air. Methylenediphosphonic acid (MDPNA)^[@r36])^ solution at a concentration of 1% (w/v) was prepared with 50% ACN with 1% TFA solution. The MDPNA solution was used for the preparation of a matrix solution with MDPNA. More than 7 sample spots were prepared for each samples.

The MALDI-MS measurements were performed using an AXIMA Performance™ (Shimadzu/Kratos, Manchester, UK) mass spectrometer equipped with a pulsed nitrogen UV laser (337 nm) in the positive ion linear mode. More than seven MALDI mass spectra for each sample were acquired from independent sample spots in the range of *m*/*z* 2000--30000. External mass calibration was carried out using two peaks of adrenocorticotropic hormone (ACTH) 18--39 (\[M + H\]^+^, *m*/*z* 2466.7) and myoglobin (\[M + H\]^+^, *m*/*z* 16952.6) followed by self-calibration using moderately strong peaks assigned to RSPs as internal references. The peak matching of the biomarker proteins was judged from tolerance within 200 ppm. Peak matching and statistical analysis were carried out using eMSTAT Solution™ software (Shimadzu Corp., Kyoto, Japan).

Identification of biomarker protein.
------------------------------------

Unidentified biomarker protein detected at *m*/*z* 7035 was purified from 250 µL of the filtration fraction in Fig. [1](#fig01){ref-type="fig"}. It was purified using a step gradient elution with 10%, 20%, and 30% ACN solution using Bond Elut Omix C4 100 µL pipette tips (Agilent Technologies Inc., Santa Clara, CA, U.S.A.). The unidentified biomarker protein was eventually eluted in the 30% ACN fraction. The obtained fraction was evaporated and dissolved in 25 µL of Milli-Q water. Tryptic peptides from the unidentified protein were obtained using sequencing grade modified trypsin (Promega, Madison, WI, U.S.A.) with incubation at 37 ℃ for 8 hours. After demineralization using ZipTip C4 (Millipore, Bedford, MA, U.S.A.), the digested sample was mixed with α-cyano-4-hydroxy cinnamic acid at a concentration of 10 mg/mL in 50% ACN solution containing 1% TFA and subjected to MALDI-MS measurement. Identification of the biomarker protein detected at *m*/*z* 7035 was carried out by using Mascot peptide mass fingerprinting (PMF) search against the NCBInr database using MASCOT (version 2.6.1, Matrix Science Ltd., London, U.K.). The database search parameters were as follows: taxonomic setting was other Actinobacteria, the number of allowed missed cleavage was 2, and average mass tolerance was set at ±150 ppm. Identification was judged if a significance score p \< 0.05 was obtained.

Cluster analysis.
-----------------

The matching of observed masses to the calculated masses was judged from a tolerance within 200 ppm. The judgement results for each biomarker protein were summarized in the binary biomarker matching table, in which scores used either 1 or 0. A dendrogram was constructed using the unweighted pair group method with arithmetic mean (UPGMA) obtained from the Euclidian distance.

Results and discussion
======================

Detection of RSPs from type strain of *C. acnes* subsp. *acnes*.
----------------------------------------------------------------

In this study, we examined bacterial sample preparation methods to detect RSPs, which are promising biomarkers to bacterial phylogenetic classification with *C. acnes* subsp. *acnes* JCM 6425^T^. Figure [2](#fig02){ref-type="fig"} shows a comparison of MALDI-MS data from bacterial samples from whole cells (a), cell lysate (b), protein fraction (c), and protein fraction with MDPNA (d); asterisks (\*) indicate RSPs. The number of detected RSPs in each MALDI-MS was as followings, whole cell, 9; cell lysate, 13; protein fraction, 22; and protein fraction with MDPNA, 31. These results suggested that sample preparation using a protein fraction with MDPMA was sufficient to detect significant numbers of RSPs. A total of nine peaks corresponding to RSPs were detected from the whole cell sample prepared using direct smear method with FA extraction (Fig. [2](#fig02){ref-type="fig"}a). Although the peaks corresponding to RSPs were relatively low, two peaks used for MALDI-MS fingerprinting^[@r17],[@r20],[@r32])^ were detected at *m*/*z* 7035 and *m*/*z* 7180 with higher intensities. Because *C. acnes* is not only a member of Gram-positive bacteria but also a biofilm producer,^[@r37]--[@r39])^ it seemed to be difficult to extract sufficient amounts of RSPs using cell lysis with an organic solvent and organic acids. In addition, microbial constituents should have negative effects on the ionization of RSPs. Cell disruption by bead beating and removing debris by centrifugation was effective to detect RSPs; however, RSPs were not observed in the range larger than *m*/*z* 14000 (Fig. [2](#fig02){ref-type="fig"}b). Although it is easy to detect RSPs from purified proteins by MALDI-MS, treatment by ultracentrifugation was needed for at least 1 hour.^[@r07]--[@r10],[@r40],[@r41])^ Here, the effect of ultracentrifugation on the detection of RSPs was to concentrate the RSPs and remove low-molecular-weight components such as minerals and peptides. We examined the purification of RSPs using ultrafiltration instead of ultracentrifugation to develop a purification method for RSPs with commonly available equipment and in a time-effectively manner. Purification of the protein fraction by ultrafiltration took only 5--10 minutes with a commonly used centrifuge with cooling function (14000 *g* at 4 ℃). Figure [2](#fig02){ref-type="fig"}c shows MALDI-MS data of protein fraction prepared by ultrafiltration. RSPs were detected in the range of *m*/*z* 4000--20000 by ultrafiltration. RSPs exist in bacterial cells as ribosome particles, and these are easily captured by ultrafiltration. Although RSPs were not completely purified by ultrafiltration, this method seemed to be sufficient to detect RSPs by MALDI-MS. Moreover, adding MDPNA improved the detection of RSPs in the higher mass range (Fig. [2](#fig02){ref-type="fig"}d). MDPNA has been proposed as additive to analyze samples that contain LC buffer. The effect of MDPNA was described as follows, improved *S*/*N* ratio, reduced generation of unnecessary adduct ions, reduced salt-induced signal suppression, and pH adjustment. The reducing salt-induced signal suppression and acidification by MDPNA was considered to be effective for clear detection of RSPs. Therefore, protein fractions prepared with MDPNA appeared to be sufficient for the analysis of RSPs of *C. acnes* strains. Details of the observed peaks are supplied in supplementary materials Table S1. We identified a number of errors in the amino acid sequences of RSPs registered in the public protein databases based on comparisons with the observed masses. The errors in amino acid sequences of registered proteins were corrected by comparison with registered amino acid sequences of other closely related genome sequenced strains. Corrected amino acid sequences for the assignment of detected peaks have been summarized with their related information such as accession numbers (supplementary materials Table S1-2 and S1-3).

Characterization of RSPs for genome-sequenced strains.
------------------------------------------------------

Peak assignment for the detected peaks from each genome-sequenced strain, *C. acnes* subsp. *acnes* JCM 6425^T^ (IA~1~), JCM 18916 (IA~1~), and JCM 18918 (IB), *C. acnes* subsp. *defendens* JCM 6473^T^ (II) and JCM 18920 (II), and *C. acnes* subsp. *elongatum* JCM 18909 (III), was carried out based on comparison with the theoretical masses calculated from the amino acid sequences of each RSP. The number of detected RSPs differed among the genome-sequenced strains. In addition to N-terminal methionine loss, which is known as a major post-translational modification for RSPs,^[@r06])^ other post-translational modifications such as disulfide binding, methylation, and acetylation are also detected in bacterial RSPs. For example, disulfide bonding, which was predicted based on a C--x--x--C motifs (C: cysteine, x: any amino acid residue) are detected in L36, L28, L31, L33, and S14. Even though disulfide binding is easy to predict from amino acid sequences, these RSPs with a C--x--x--C motif are removed from biomarkers because peak shifts by −4 or −2 were not always detected in this study. Furthermore, RSPs whose mass differences were smaller than 200 ppm, such as L7/12 (*m*/*z* 13571.4) and L18 (*m*/*z* 13570.6), were removed from the biomarkers because these peaks were too close to discriminate from each other. About 25 to 30 RSPs were assigned for all the sample strains with repeatability in the range of *m*/*z* 4000--20000 (Table SI-2 and SI-3.). A total of 11 RSPs summarized in Table [2](#tbl02){ref-type="table"} are biomarker candidates to classify *C. acnes* phylotypes. These RSPs were commonly detected from six genome-sequenced strains used in this study. Each of the six biomarker proteins, L9, L29, L30, S8, S15, and S19, were detected at the same *m*/*z* values among the genome-sequenced strains used in this study. In contrast, there were slight mutations in amino acid sequences in L6, L13, L15, and L23, and these RSPs were expected to contribute to the classification of *C. acnes* strains.

Phylotype classification of *C. acnes* strains.
-----------------------------------------------

The biomarker candidates to classify *C. acnes* phylotypes in Table [2](#tbl02){ref-type="table"} were reproducibly detected from all of the sample strains used in this study. Mass-matching profiles of the RSP biomarkers, which were denoted as 0 or 1 (1: detected, 0: not detected) and the resultant dendrogram together with their types and phylotypes is shown in Fig. SI-1. Types I, II, and III were classified using RSP biomarkers. Here, the most important issue in this study was differentiation of each phylotype within *C. acnes* subsp. *acnes* (type I), IA~1~, IA~2~, and IB. From this perspective, L13 was a crucially important biomarker protein to discriminate IB from IA~1~ and IA~2~, which was impossible to discriminate using the fingerprinting method.^[@r17])^ Although IB was differentiated from IA~1~ and IA~2~, IA~1~ and IA~2~ were not discriminated. Furthermore, *C. acnes* subsp. *acnes* JCM 18916 (IA~1~) deviated from the IA~1~ cluster because of the mutation of amino acid residue in L27. At present (July 26, 2019), more than 250 amino acid sequences of L27 for *C. acnes* are registered in the protein databases. Here, the amino acid sequence of L27 of *C. acnes* JCM 18916 is supposed to be unique in *C. acnes* strains, because only 5 strains (HL002PA2, HL002PA3, HL036PA2, HL036PA3, and HL046PA2) had the same sequences. Although L27 seemed to be a potentially effective biomarker protein to further classify IA~1~ strains, this RSP was removed from biomarker protein in order to make a single cluster for IA~1~ and also to classify *C. acnes* subsp. *acnes* JCM 18916 into the IA~1~ cluster. In addition, strains of type II were classified into two clusters based on L13, whose sequence types (STs) analyzed by MLST were 42 and 46, and others.^[@r42])^ In order to discriminate IA~1~ and IA~2~, a biomarker candidate was selected using statistical analysis with eMSTAT Solution software. As a result, it was indicated that a peak detected at *m*/*z* 7035 was specific for IA~1~ strains. Although this peak had not been characterized, it has been used by other researchers^[@r17],[@r20],[@r32])^ to discriminate phylotypes of *C. acnes* strains using the MALDI-MS fingerprinting approach. Because the peak was detected with high intensity using the direct smear method using the whole cell (Fig. [2](#fig02){ref-type="fig"}a), it was considered to be a non-cytoplasmic protein. In addition, the protein was presumed to be a non-ribosomal protein because it was removed from cell-lysates by ultrafiltration. Furthermore, proteome of *C. acnes* ATCC 6919^T^ (= JCM 6425^T^) has already been studied.^[@r43])^ In the study, CsbD-like protein and hypothetical protein PPA1018 were reported as abundant cell wall proteins whose molecular weight was about 7000. First, we calculated the theoretical masses of these proteins. The calculated *m*/*z* values for the \[M + H\]^+^ ion of CsbD-like protein was 7179.9, and that for hypothetical protein PPA1018 was 7034.6. Moreover, hypothetical protein PPA1018 was identified as an antitoxin by homology searches for amino acid sequences of the protein. Amino acid sequences and calculated masses considering N-terminal methionine loss are summarized with their accession numbers in Table [3](#tbl03){ref-type="table"}. To verify our prediction, we also analyzed whole cells of sample strains using the direct smear method. MALDI-MS data from each phylotype of genome-sequenced strains in the range *m*/*z* 6900--7300 are shown in Fig. [3](#fig03){ref-type="fig"}. Two to three peaks were detected at different *m*/*z* values reflecting their phylotypes. Peaks were successfully matched with the calculated masses for antitoxins and CsbD-like proteins. Our data supported the results reported by Dekio *et al.*,^[@r17],[@r20])^ and these results suggested that IA~2~ and IB were not distinguished using antitoxin and CsbD-like protein as biomarkers. On the other hand, Nagy *et al.* reported that IA~1~ and IA~2~ were not distinguished by MALDI-MS fingerprinting technique, because both of their characteristic peaks were in common at *m*/*z* 7034 and 7180.^[@r32])^ Although their results did not agree with ours, the theoretical masses of antitoxin for three strains of *C. acnes* phylotype IA~2~ (P.acn17, P.acn31, and P.acn33) used in their study^[@r32])^ were *m*/*z* 7005, which agreed with our assumption. Moreover, the predominant peaks detected in the range of *m*/*z* 3450--3650 and *m*/*z* 6950--7300 were reported.^[@r20])^ These peaks seemed to be \[M + 2H\]^2+^ and \[M + H\]^+^ corresponding to antitoxin and CsbD-like protein for each phylotype. Here, we decided to add antitoxin, which was detected at *m*/*z* 7035 as biomarker proteins to discriminate IA~1~ and IA~2~. In addition, PMF analysis of purified antitoxin of *C. acnes* subsp. *acnes* JCM 6425^T^ was made from fragments derived through trypsin digestion (Fig. SI-2a). The expected tryptic masses clearly matched the calculated values within 150 ppm differences, as shown in Fig. SI-2b. This result also supported our prediction that the peak detected at *m*/*z* 7035 corresponded to an antitoxin. We examined the effectiveness of these two kinds of proteins as biomarkers. Although antitoxin and CsbD-like protein were major peaks when bacterial samples were prepared using the direct smear method, these were not major peaks in the MALDI-MS data of protein fractions. In addition, antitoxin of *C. acnes* subsp. *elongatum* was not always detected as reported by Dekio *et al.*^[@r17],[@r20])^ For these reasons, we decided that addition of antitoxin to IA~1~ as a biomarker was suitable. In other words, observing the presence or absence of antitoxin for IA~1~ was more suitable for the discrimination of IA~1~ and IA~2~. The biomarker matching table (Table [4](#tbl04){ref-type="table"}) was processed by UPGMA cluster analysis to generate a dendrogram. Figure [4](#fig04){ref-type="fig"} shows the resulting dendrogram of *C. acnes* strains together with their phylotypes. A total of 24 *C. acnes* strains used in this study were split into three major clusters that correlated with traditional phylogenetic classification defined as types I, II, and III by two RSPs selected from L23, L15, and L6. In addition, members of type I were classified into phylotypes as IA~1~, IA~2~, and IB by L13 and antitoxin. As a result, we successfully classified 24 strains of *C. acnes* phylotypes based on 10 RSPs and antitoxin for IA~1~. Here, classification of IC could be evaluated on a theoretical level, because we did not have IC strains. Theoretical masses of the biomarkers for IC strains were able to be calculated from their amino acid sequences of genome sequenced IC strains, HL097PA1 and PRP-38, and are summarized in Table SI-4. Based on the estimation from amino acid sequences of each protein of IC strains, IC strains were considered to be discriminated from other phylotypes by L23. It should be noted that IC strains will not be discriminated from IA~2~ and IB by the fingerprinting method using two peaks, which were assigned as antitoxin and CsbD-like protein, because the calculated masses of these proteins were same as IA~2~ and IB (Table SI-4). This is the first report that has successfully classified IA~1~, IA~2~, and IB by MALDI-MS proteotyping. It is important to detect as many biomarkers as possible to better understand the diversity of *C. acnes* strains. On the other hand, we proposed a workflow for the rapid identification of phylotypes of *C. acnes* strains by MALDI-MS proteotyping in Fig. [5](#fig05){ref-type="fig"}. This workflow enabled the identification of *C. acnes* phylotypes IA~1~, II, and III with a combination of two biomarker proteins, antitoxin and CsbD-like protein, and IA~2~, IB, and IC were identified with a combination of five biomarker proteins, antitoxin, CsbD-like protein, L6, L13, and L23. Our proposed workflow should be effective for the identification of phylotypes for a large number of *C. acnes* strains.

This is the first report that has successfully classified the phylotypes of *C. acnes* strains as IA~1~, IA~2~, IB, II, and III based on MALDI-MS proteotyping using assigned biomarker proteins such as RSPs and antitoxin. Although IC strains were not available for this study, theoretical masses, which were calculated from the amino acid sequences for IC strains, indicated that the phylotypes for IC strains will be identified correctly. Further study using IC strains is required to verify our approach. Although MLST is widely recognized as the gold-standard technique allowing the discrimination of phylotypes of *C. acnes*, our proposed method is still a viably important workflow, which enabled us to discriminate phylotypes of *C. acnes* independently from a DNA-based technique.

Supplementary materials
=======================

Table SI-1: Detected ribosomal proteins of *C. acnes* JCM 6425^T^. Table SI-2-1 to SI-2-24: Tables for detected ribosomal proteins of sample strains. Table SI-3: Corrected amino acid sequences of biomarker RSPs of genome sequenced strains. Table SI-4: Calculated masses for phylotype IC strains. Fig. SI-1: Biomarker matching table in a binary format of the sample strains (a) and resultant dendrogram of *C. acnes* strains based on variation of the 11 RSPs (b). Fig. SI-2: MALDI peptide mass fingerprint spectrum of the protein detected at *m*/*z* 7035 (a) and matched peptide fragments from the tryptic digestion of the protein (b). The sequence coverage of these fragments is shown in bold.

These materials are available free at [https://doi.org/10.2183/pjab.95.042](https://doi.org/10.2183/pjab.95).
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![Preparation procedure of the bacterial samples.](pjab-95-612-g001){#fig01}

![Comparison of observed ribosomal subunit proteins from *C. acnes* subsp. *acnes* JCM 6425^T^ cells with different sample preparation methods. Direct smear method with 30% FA extraction (a), premixed method with cell-lysate by bead beading (b), premixed method with protein fractions obtained by ultrafiltration (c), and premixed method with the protein fraction obtained by ultrafiltration in MDPNA (d). Asterisks (\*) indicate the ribosomal subunit proteins.](pjab-95-612-g002){#fig02}

![MALDI-MS of whole cells for *C. acnes* strains prepared using the direct smear method. JCM 6425^T^ (a), JCM 18910 (b), JCM 18918 (c), JCM 6473^T^ (d), JCM 18920 (e) and JCM 18909 (f). Detected *m*/*z* values are indicated in the mass spectra. These are matched with the calculated masses of antitoxin and CsbD-like protein within the tolerance, respectively. These amino acid sequences are shown in the Table [3](#tbl03){ref-type="table"}.](pjab-95-612-g003){#fig03}

![Dendrogram of *C. acnes* strains based on variation of the 10 RSPs and antitoxin.](pjab-95-612-g004){#fig04}

![Workflow for the rapid identification of phylotypes of *C. acnes* by MALDI-MS proteotyping.](pjab-95-612-g005){#fig05}

###### 

Sample strains of *C. acnes*

  Culture collection number                  Phylotype^a^   Sequence type   Sample name^a^   
  ------------------------------------------ -------------- --------------- ---------------- ------
  *C. acnes* subsp. *acnes* (type I)                                                         
  JCM                                        6425^T^        IA~1~           6^b^             ---
  JCM                                        6495           IA~1~           ---              ---
  JCM                                        18916          IA~1~           6^a^             K107
  JCM                                        18922          IA~1~           6^a^             K161
  JCM                                        18924          IA~1~           6^a^             K282
  JCM                                        18907          IA~2~           22^a^            K51
  JCM                                        18908          IA~2~           9^a^             K56
  JCM                                        18910          IA~2~           22^a^            K72
  JCM                                        18912          IA~2~           9^a^             K94
  JCM                                        18917          IB              10^a^            K114
  JCM                                        18918          IB              10^a^            K115
  JCM                                        18923          IB              10^a^            K280
  JCM                                        18927          IB              10^a^            S16
                                                                                             
  *C. acnes* subsp. *defendens* (type II)                                                    
  JCM                                        6473^T^        II              ---              ---
  JCM                                        18911          II              43^a^            K80
  JCM                                        18913          II              46^a^            K96
  JCM                                        18914          II              43^a^            K104
  JCM                                        18915          II              43^a^            K106
  JCM                                        18920          II              43^a^            K127
  JCM                                        18921          II              43^a^            K145
  JCM                                        18926          II              42^a^            S13
                                                                                             
  *C. acnes* subsp. *elongatum* (type III)                                                   
  JCM                                        18909          III             19^a^            K57
  JCM                                        18919^T^       III             19^a^            K124
  JCM                                        18925          III             19^a^            K290

a: Dekio *et al.* *J Med Microbiol* (2012) 61, 622--630.

b: McDowell *et al. Microbiology* (2011) 157, 1990--2003.

###### 

Biomarker candidates selected from RSPs

  Protein name   Calculated masses                 
  -------------- ------------------- ------------- -------------
  L6             1\) 19678.6         2\) 19706.6    
  L9             1\) 16118.8                        
  L13            1\) 16153.5         2\) 16167.6   3\) 16181.6
  L15            1\) 15357.6         2\) 15384.7    
  L23            1\) 11181.0         2\) 11200.0    
  L27            1\) 9362.4          2\) 9392.4     
  L29            1\) 8754.9                         
  L30            1\) 6786.9                         
  S8             1\) 14525.7                        
  S15            1\) 10080.7                        
  S19            1\) 10380.0                        

###### 

Amino acid sequences of antitoxin and CsbD-like protein with calculated masses

  Antitoxin (66 aa)
  -----------------------------------------------------------------------------------------------
   Calculated mass: *m*/*z* 7034.6 (IA~1~)
   MGLFDKAKDAISD[R]{.ul}QDDIKNQASQHSDQVEQGIDKAGN[T]{.ul}VDDKTGGKFSDQIDKGQDALKDKLGDL
   Calculated mass: *m*/*z* 7004.5 (IA~2~, IB, IC, and III)
   MGLFDKAKDAISD[R]{.ul}QDDIKNQASQHSDQVEQGIDKAGN[A]{.ul}VDDKTGGKFSDQIDKGQDALKDKLGDL
   Calculated mass: *m*/*z* 6985.5 (II)
   MGLFDKAKDAISD[H]{.ul}QDDIKNQASQHSDQVEQGIDKAGN[A]{.ul}VDDKTGGKFSDQIDKGQDALKDKLGDL
  CsbD-like protein (71 aa)
   Calculated mass: *m*/*z* 7179.9 (IA~1~, IA~2~, IB, IC and III)
   MGLSDKINSKSDEAVGAAKEKIGGLTDDSDLKS[A]{.ul}GA[D]{.ul}QKASGKVAQKVEDVKDKANDLKHN[V]{.ul}QAAADKLKG
   Calculated mass: *m*/*z* 7238.0 (III)
   MGLSDKINSKSDEAVGAAKEKIGGLTDDSDLKS[E]{.ul}GA[D]{.ul}QKASGKVAQKVEDVKDKANDLKHN[V]{.ul}QAAADKLKG
   Calculated mass: *m*/*z* 7251.0 (II, ST 42 and 46)
   MGLSDKINSKSDEAVGAAKEKIGGLTDDSDLKS[E]{.ul}GA[N]{.ul}QKASGKVAQKVEDVKDKANDLKHN[I]{.ul}QAAADKLKG
   Calculated mass: *m*/*z* 7265.0 (II, ST 43)
   MGLSDKINSKSDEAVGAAKEKIGGLTDDSDLKS[E]{.ul}GA[N]{.ul}QKASGKVAQKVEDVKDKANDLKHN[V]{.ul}QAVADKLKG

Underlines in the amino acid sequences indicate mutated amino acid residues.

###### 

Biomarker matching table in a binary format of the sample strains

  Strains    Biomarker proteins                                                               
  ---------- -------------------- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
  IA~1~      6425^T^              1   1   1   1   1   1   1   0   1   0   1   0   0   1   0   1
  6495       1                    1   1   1   1   1   1   0   1   0   1   0   0   1   0   1   
  18916      1                    1   1   1   1   1   1   0   1   0   1   0   0   1   0   1   
  18922      1                    1   1   1   1   1   1   0   1   0   1   0   0   1   0   1   
  18924      1                    1   1   1   1   1   1   0   1   0   1   0   0   1   0   1   
                                                                                              
  IA~2~      18907                1   1   1   1   1   1   0   0   1   0   1   0   0   1   0   1
  18908      1                    1   1   1   1   1   0   0   1   0   1   0   0   1   0   1   
  18910      1                    1   1   1   1   1   0   0   1   0   1   0   0   1   0   1   
  18912      1                    1   1   1   1   1   0   0   1   0   1   0   0   1   0   1   
                                                                                              
  IB         18917                1   1   1   1   1   1   0   0   1   1   0   0   0   1   0   1
  18918      1                    1   1   1   1   1   0   0   1   1   0   0   0   1   0   1   
  18923      1                    1   1   1   1   1   0   0   1   1   0   0   0   1   0   1   
  18927      1                    1   1   1   1   1   0   0   1   1   0   0   0   1   0   1   
                                                                                              
  II         6473^T^              1   1   1   1   1   1   0   1   0   0   0   1   1   0   0   1
  18911      1                    1   1   1   1   1   0   1   0   0   0   1   1   0   0   1   
  18914      1                    1   1   1   1   1   0   1   0   0   0   1   1   0   0   1   
  18915      1                    1   1   1   1   1   0   1   0   0   0   1   1   0   0   1   
  18920      1                    1   1   1   1   1   0   1   0   0   0   1   1   0   0   1   
  18921      1                    1   1   1   1   1   0   1   0   0   0   1   1   0   0   1   
  18913      1                    1   1   1   1   1   0   1   0   0   1   0   1   0   0   1   
  18926      1                    1   1   1   1   1   0   1   0   0   1   0   1   0   0   1   
                                                                                              
  III        18909                1   1   1   1   1   1   0   1   0   1   0   0   0   1   1   0
  18919^T^   1                    1   1   1   1   1   0   1   0   1   0   0   0   1   1   0   
  18925      1                    1   1   1   1   1   0   1   0   1   0   0   0   1   1   0   

[^1]: (Communicated by Koichi TANAKA, M.J.A.; Edited by Masanori OTSUKA, M.J.A.)
